Research Papers

25 of 89 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Peripheral neuropathies during the COVID-19 pandemic: is there a relation?
Trentinaglia M; Lippi G; Salvagno GL; Rispoli MG; De Angelis MV; Castellani F; Alberti D; Maniscalco GT; Rossi F; Turri M; Rossi P; Del Zotto E; Fusina S; Cardellini D; Zivelonghi C; Volonghi I; Monaco S; Briani C; Ferrari S; Mariotto S.
Immunol Res (Unknown)
Published: 2022
2/6 Transparent
Identification of nafamostat mesylate as a selective stimulator of NK cell IFN-γ production via metabolism-related comp…
Yang Q; Zhang S; Wu S; Yao B; Wang L; Li Y; Peng H; Huang M; Bi Q; Xiong P; Li L; Deng Y; Deng Y.
Immunol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases.
Shi N; Wang Z; Zhu H; Liu W; Zhao M; Jiang X; Zhao J; Ren C; Zhang Y; Luo L.
Immunol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Differential blood leukocyte populations based on individual variances and age.
Kasten-Jolly J; Lawrence DA.
Immunol Res (Unknown)
Published: 2022
2/6 Transparent
The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phospho…
Joyo Y; Kawaguchi Y; Yonezu H; Senda H; Yasuma S; Shiraga H; Nozaki M; Aoyama M; Asai K; Murakami H; Waguri-Nagaya Y.
Immunol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy?
Vitiello A; Ferrara F.
Immunol Res (Unknown)
Published: 2021
2/6 Transparent
Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly p…
Malipiero G; Moratto A; Infantino M; D'Agaro P; Piscianz E; Manfredi M; Grossi V; Benvenuti E; Bulgaresi M; Benucci M; Villalta D.
Immunol Res (Unknown)
Published: 2021
2/6 Transparent
COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells.
Wenzhong L; Hualan L.
Immunol Res (Unknown)
Published: 2021
4/6 Transparent
Data Funding Declared
Hidradenitis suppurativa and rheumatoid arthritis: evaluating the bidirectional association.
Kridin K; Shavit E; Damiani G; Cohen AD.
Immunol Res (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae?
Bozzetti S; Ferrari S; Zanzoni S; Alberti D; Braggio M; Carta S; Piraino F; Gabbiani D; Girelli D; Nocini R; Monaco S; Crisafulli E; Mariotto S.
Immunol Res (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n…
Kelleni MT.
Immunol Res (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Activation of autophagy reverses gemcitabine-induced immune inhibition of RAW264.7 macrophages by promoting TNF-α, IL-6…
Jiang S; Wang R; Han L; Kuerban K; Ye L; Pan S; Li S; Yuan Y.
Immunol Res (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review.
Komal A; Noreen M; El-Kott AF.
Immunol Res (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Iodoprophylaxis and thyroid autoimmunity: an update.
Teti C; Panciroli M; Nazzari E; Pesce G; Mariotti S; Olivieri A; Bagnasco M.
Immunol Res (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Chronic renal comorbidities in pyoderma gangrenosum: a retrospective cohort study.
Kridin K; Solomon A; Britva RL; Bitan DT; Cohen AD.
Immunol Res (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series …
Blitshteyn S; Whitelaw S.
Immunol Res (Unknown)
Published: 2021
1/6 Transparent
Native and IgE-primed rat peritoneal mast cells exert pro-inflammatory activity and migrate in response to yeast zymosa…
Żelechowska P; Brzezińska-Błaszczyk E; Różalska S; Agier J; Kozłowska E.
Immunol Res (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Dexmedetomidine alleviates pulmonary edema through the epithelial sodium channel (ENaC) via the PI3K/Akt/Nedd4-2 pathwa…
Jiang Y; Xia M; Xu J; Huang Q; Dai Z; Zhang X.
Immunol Res (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement.
Quattrocchio G; Barreca A; Demarchi A; Fenoglio R; Ferro M; Del Vecchio G; Massara C; Rollino C; Sciascia S; Roccatello D.
Immunol Res (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.
Li X; Liu Y; Li J; Sun L; Yang J; Xu F; Zhou J; Wan L; Xu X; Le A; Zhang W.
Immunol Res (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.
Kanduc D; Shoenfeld Y.
Immunol Res (Unknown)
Published: 2020
1/6 Transparent
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
Perricone C; Bartoloni E; Bursi R; Cafaro G; Guidelli GM; Shoenfeld Y; Gerli R.
Immunol Res (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Jeffrey's insights: Jeffrey Modell Foundation's global genetic sequencing pilot program to identify specific primary im…
Quinn J; Modell V; Holle J; Truty R; Aradhya S; Johnson B; Orange J; Modell F.
Immunol Res (Unknown)
Published: 2020
1/6 Transparent
Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris.
Juczynska K; Wozniacka A; Waszczykowska E; Danilewicz M; Wągrowska-Danilewicz M; Zebrowska A.
Immunol Res (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different…
Ravindranath MH; Filippone EJ; Mahowald G; Callender C; Babu A; Saidman S; Ferrone S.
Immunol Res (Unknown)
Published: 2018
2/6 Transparent
Funding Declared